Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: The simvastatin and ezetimibe in aortic stenosis study

Circulation

Volumn 125, Issue 2, 2012, Pages 346-353

  Greve, Anders M ^a   Boman, Kurt ^b   Gohlke Baerwolf, Christa ^c   Kesäniemi, Y Antero ^d   Nienaber, Christoph ^e   Ray, Simon ^f   Egstrup, Kenneth ^g   Rossebø, Anne B ^h   Devereux, Richard B ^k   Køber, Lars ^a   Willenheimer, Ronnie ^j   Wachtell, Kristian ^a,i  

^a Rigshospitalet   (Denmark)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^d UNIVERSITY OF OULU   (Finland)

^e ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^f MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^g OUH Svendborg Sygehus   (Denmark)

^h ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

ⁱ GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^j LUND UNIVERSITY   (Sweden)

^k WEILL CORNELL MEDICAL COLLEGE   (United States)

more..

Author keywords

asymptomatic aortic stenosis; hypertrophy; risk stratification; strain

Indexed keywords

EZETIMIBE PLUS SIMVASTATIN; PLACEBO;

AGED; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CONTROLLED STUDY; DEATH; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE STRAIN; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STROKE; T WAVE; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; AZETIDINES; CARDIOVASCULAR DISEASES; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; SIMVASTATIN; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84856098757     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.049759     Document Type: Article

References (18)

1. Lund O, Nielsen TT, Emmertsen K, Flo C, Rasmussen B, Jensen FT, Pilegaard HK, Kristensen LH, Hansen OK. Mortality and worsening of prognostic profile during waiting time for valve replacement in aortic stenosis. Thorac Cardiovasc Surg. 1996;44:289-295. (Pubitemid 27032234)
2. Hering D, Piper C, Horstkotte D. Influence of atypical symptoms and electrocardiographic signs of left ventricular hypertrophy or ST-segment/ T-wave abnormalities on the natural history of otherwise asymptomatic adults with moderate to severe aortic stenosis: Preliminary communication. J Heart Valve Dis. 2004;13:182-187.
3. Ross J Jr, Braunwald E. Aortic stenosis. Circulation. 1968;38:61-67.
4. Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Barwolf C, Holme I, Kesaniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359:1343-1356.
5. Rossebo AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, Gerdts E, Gohlke-Barwolf C, Holme I, Kesaniemi VA, Malbecq W, Nienaber C, Ray S, Skjaerpe T, Wachtell K, Willenheimer R. Design and baseline characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study. Am J Cardiol. 2007;99:970-973. (Pubitemid 46483289)
6. Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebo AB, Hammer-Hansen S, Kober L, Willenheimer R, Wachtell K. Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data). Am J Cardiol. 2011;108:541-547.
7. Prineas RJ, Crowe RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Bristol, UK: John Wright; 1982:298.
8. Cramariuc D, Cioffi G, Rieck AE, Devereux RB, Staal EM, Ray S, Wachtell K, Gerdts E. Low-flow aortic stenosis in asymptomatic patients: Valvular-arterial impedance and systolic function from the SEAS Substudy. J Am Coll Cardiol Cardiovasc Imaging. 2009;2:390-399.
9. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinones M. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr. 2009;10:1-25.
10. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463. (Pubitemid 41821197)
11. Fine JP, Gray RJ. A proportional hazard model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
12. Levey AS, Greene T, Kusek JW, Beck GL. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:A0828.
13. Anderson HV, Stokes MJ, Leon M, Abu-Halawa SA, Stuart Y, Kirkeeide RL. Coronary artery flow velocity is related to lumen area and regional left ventricular mass. Circulation. 2000;102:48-54. (Pubitemid 30430552)
14. Villari B, Hess OM, Moccetti D, Vassalli G, Krayenbuehl HP. Effect of progression of left ventricular hypertrophy on coronary artery dimensions in aortic valve disease. J Am Coll Cardiol. 1992;20:1073-1079.
15. Tomanek RJ, Palmer PJ, Peiffer GL, Schreiber KL, Eastham CL, Marcus ML. Morphometry of canine coronary arteries, arterioles, and capillaries during hypertension and left ventricular hypertrophy. Circ Res. 1986;58:38-46. (Pubitemid 16165931)
16. van den Heuvel AF, van Veldhuisen DJ, van der Wall EE, Blanksma PK, Siebelink HM, Vaalburg WM, van Gilst WH, Crijns HJ. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2000;35:19-28. (Pubitemid 30061254)
17. Julius BK, Spillmann M, Vassalli G, Villari B, Eberli FR, Hess OM. Angina pectoris in patients with aortic stenosis and normal coronary arteries: Mechanisms and pathophysiological concepts. Circulation. 1997; 95:892-898. (Pubitemid 27091530)
18. Luo JD, Zhang WW, Zhang GP, Guan JX, Chen X. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis. Clin Exp Pharmacol Physiol. 1999;26:903-908. (Pubitemid 29513630)